Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q2

4502.TEDINET S100S2Q9
Period2023-04-01 → 2023-09-30
Filed2023-10-30
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥2.10T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥1.04T2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥4.03T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.97T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.00T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income¥119.2bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥49.3bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥255.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥104.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥39.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥96.0bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥375.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥220.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥64.5bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥48.0bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥48.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥14.87Tat 2023-09-30Cons.Assets IFRS
Total assets¥13.96Tat 2023-03-31Cons.Assets IFRS
Total assets¥14.59Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.80Tat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥7.60Tat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥7.07Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥6.35Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥6.71Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥7.07Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.35Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥318.1bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥798.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥291.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥305.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥327.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥121.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥198.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥267.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥26.512023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-30.682023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥204.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥107.622022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥26.292023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-30.682023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥201.942022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥106.882022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥39.482022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio47.5%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio46.0%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 751
ItemContextValueUnit
Selling general and administrative expenses IFRSCurrentQuarterDuration252952000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration154145000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration183946000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSPrior1QuarterDuration142366000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSCurrentQuarterDuration240242000000JPY
Other operating income IFRSPrior1QuarterDuration7997000000JPY
Other operating income IFRSCurrentQuarterDuration5670000000JPY
Other operating expenses IFRSPrior1QuarterDuration55177000000JPY
Other operating expenses IFRSCurrentQuarterDuration77379000000JPY
Operating profit loss IFRSPrior1QuarterDuration104438000000JPY
Operating profit loss IFRSCurrentQuarterDuration-49342000000JPY
Finance income IFRSPrior1QuarterDuration14782000000JPY
Finance income IFRSCurrentQuarterDuration9359000000JPY
Finance costs IFRSPrior1QuarterDuration53803000000JPY
Finance costs IFRSCurrentQuarterDuration58022000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration-869000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration2025000000JPY
Profit loss before tax IFRSPrior1QuarterDuration64549000000JPY
Profit loss before tax IFRSCurrentQuarterDuration-95980000000JPY
Income tax expense IFRSPrior1QuarterDuration2817000000JPY
Income tax expense IFRSCurrentQuarterDuration-48009000000JPY
Profit loss IFRSPrior1QuarterDuration61732000000JPY
Profit loss IFRSCurrentQuarterDuration-47971000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration61742000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration-48030000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration-10000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration59000000JPY
Profit loss IFRSPrior1QuarterDuration61732000000JPY
Profit loss IFRSCurrentQuarterDuration-47971000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration39.77
Basic earnings loss per share IFRSCurrentQuarterDuration-30.68
Diluted earnings loss per share IFRSPrior1QuarterDuration39.48
Diluted earnings loss per share IFRSCurrentQuarterDuration-30.68
Profit loss IFRSPrior1YTDDuration166753000000JPY
Profit loss IFRSCurrentYTDDuration41436000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration5284000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration6537000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration13395000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration2644000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration18679000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration9181000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration1035192000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration779220000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-33200000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-2015000000JPY
Hedging cost net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-22749000000JPY
Hedging cost net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-2579000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-1085000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-279000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration978158000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass